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A major consideration in the development of combined Salmonella vaccines is obtaining a sufficiently high level of expression of the recombinant antigen in the Salmonella strain to trigger an immune response. However, unregulated high-level expression of foreign antigens can be toxic and affect cell viability, rendering the Salmonella carrier ineffective or causing loss ofthe recombinant DNA (reviewed in ref. 9 ). An elegant approach that has been applied in mycobacteria is to use heat-shock promoters that are inducible in vivo to express foreign antigens (10) .
The latter approach has also met with considerable success in Salmonella, by using the Escherichia coli nitrite reductase promoter nirB, which is induced under anaerobiosis, to drive the expression ofthe atoxic but highly immunogenic fragment C of tetanus toxin (TetC) (11) . A Salmonella Aro strain harboring this construct (pTETnirl5) elicited very high antitetanus antibody responses in mice (11) . The animals were protected against subsequent challenge with tetanus toxin following a single oral dose ofthe vaccine. Tetanus toxoid has been extensively used as an adjuvant for chemically coupled antigens (12) . The potent immunogenicity of TetC in Salmonella suggests that it may be possible to exploit this character to promote the immune response to guest antigens. The genetic fusion of a guest antigen to a carrier protein is very attractive, as it allows a precise fusion ofdefined composition to be made. However, fusing two proteins together often leads to an incorrectly folded chimeric protein that no longer retains the properties of individual components. The B subunit of the Vibrio cholerae (CT-B) and E. coli (LT-B) enterotoxins are powerful mucosal immunogens Genetic fusions to these subunits can alter the structure and properties of the carrer and hence their immunogenicity (13, 14) . The successful use of LT-B as a fusion partner by incorporating a short flexible hinge region at the C terminus of LT-B into which guest peptides can be cloned has been reported (15, 16 
MATERIALS AND METHODS
Plasmids, Oligonucleotides, the Polymerase Chain Reaction (PCR), and Bacterial Strains. The plasmid pTETnirl5 directs the expression of TetC under the control of the nirB promoter (11) . The TetC-hinge fusion vector pTECH1 was in part constructed from pTETnir15 by the PCR (17) . PCR was performed by using the high-fidelity thermostable DNA polymerase from Pyrococcus furiosus, which possesses an associated 3',5'-exonuclease proofreading activity (18) . A TetChinge replacement cassette was synthesized by using the primers listed in Fig. 1 Anti-P28 antibodies were detected as above, coating the plates with 1 1Lg of recombinant P28 per well as described (24) .
Tetanus Toxin and SalmoneUa Challenge. Mice were challenged with 50 LD50 doses of tetanus toxin as described (25) .
Each mouse was injected subcutaneously in a hind leg with 50 ng oftetanus toxin in a 0.2-ml solution of50% bovine heart infusion/50% PBS, 28 days postimmunization. Mice that developed symptoms of tetanic paralysis were humanely euthanized and survivors were recorded after 4 days.
Mice were challenged orally with 109 cfu of the mouse virulent S. typhimurium strain C5, which has an oral LD50 of 106 cfu in BALB/c mice (21) .
RESULTS
Design and Construction ofthe Expression Vectors. A vector for the expression of guest antigens as C-terminal fusions to TetC via a short intervening hinge region and driven by the nirB promoter, designated pTECH1, was constructed by modifying the existing pTETnirl5 plasmid (11) by the following approach. Convenient restriction sites, preceded by a hinge region encoding a Gly-Pro-Gly-Pro motif, were introduced at the 3' end of the TetC coding region by means of primers tailored with "add-on" adaptor sequences ( Fig. 1 ) using the PCR (17) . Essentially the strategy involved the amplification of a segment ofDNA from the unique Sac II site within the TetC gene to the final codon (Fig. 2) . The antisense primer in this amplification reaction was tailored with a 38-base 5'-adaptor sequence (Fig. 1) . In general, adaptor sequences for cloning PCR products are <10 bp in length (26) . This unusually long 38-base add-on sequence did not appear to affect the viability or specificity ofthe amplification reaction (data not shown). The product was gel-purified, digested with Sac II and BamHI, and then cloned into the residual 2.8-kb pTETnirl5 vector, which had been previously digested with the respective enzymes. This vector was designated pTECH1 (Fig. 2) .
The hinge region was designed to promote the independent folding of the carrier and guest proteins by providing spatial and temporal separation between the domains. The same rationale was used for the design of an LTB fusion vector (15) . The hinge region was synthesized to encode for a Gly-Pro repeat motif, as such regions are present in a number of different proteins and are thought to demarcate protein domains (27) (28) and Salmonella were selected to encode for the hinge, as such rare codons are thought to cause ribosomal pausing during translation of the mRNA and allow for the correct folding of polypeptide domains (29) . In addition, where possible, restriction enzymes were chosen for the cloning region that, when translated in the resulting fusion, does not encode for bulky side groups.
A P28 gene expression cassette was produced by PCR using as template P28 cDNA that had been cloned into pUC19. Oligonucleotide primers were designed to amplify the full-length P28 gene beginning with the start codon and terminating with the stop codon (Fig. 1) . In addition, the sense and antisense primers were tailored with the restriction sites for Xba I and BamHI, respectively. The product was gel-purified and digested with Xba I and BamHI and then cloned into pTECH1, which had previously been digested with these enzymes and subsequently gel-purified (Fig. 2) .
Analysis of Protein Expression. Expression of the TetC-P28 fusion protein was evaluated by SDS/PAGE and Western blotting of bacterial cells harboring the construct. The fusion protein remains soluble, reacts with antisera to TetC and P28, and is also of the expected molecular mass, 80 kDa, for a full-length fusion (Fig. 3) . However, it has been estimated that the level of expression of the TetC-P28 fusion is =2-fold lower than that ofTetC from pTECH1, which itselfexpresses TetC "3-fold less than the parental pTETnirl5 vector (data not shown).
The fusion protein is stably expressed in a number of different genetic backgrounds, including E. coli TG2 and S. typhimurium SL5338 (data not shown) and also SL3261, as judged by SDS/PAGE and Western blotting (Fig. 3) . Of interest, a band of 50 kDa that comigrates with the TetChinge protein alone and reacts exclusively with the anti-TetC sera is visible in a Western blot (Fig. 3, lanes 4) . As the codon A selection in the hinge region has been designed to be suboptimal, the rare codons may cause pauses during translation, which may lead to the premature termination of translation, thus accounting for the band.
The amino acid residues of glutathione S-transferases involved in binding glutathione are thought to be spatially separated in the primary structure of the polypeptide and brought together to form a glutathione binding pocket in the tertiary structure (30) . To gauge whether the P28 component of the fusion has folded correctly to adopt a conformation capable of binding glutathione, we tested its ability to be affinity purified on a glutathione-agarose matrix. The results suggest that the TetC-P28 fusion protein can indeed bind to the matrix and the binding is reversible, as the fusion can be competitively eluted with free glutathione (data not shown).
Immunogenicity of Constructs. Viable counts performed on
homogenates of liver, spleen, and lymph nodes of groups of mice inoculated intravenously and orally with SL3261, SL3261(pTECH1), and SL3261(pTECHl-P28) showed that the recombinant construct grew and persisted in the tissues in a manner very similar to that of the parent strain. Viable counts of SL3261(pTECH1-P28) on media with and without ampicillin were very similar for up to 11 days after inoculation, indicating that the plasmid was not being lost in vivo (data not shown).
Tail bleeds were taken at weeks 4 and 7 from all 16 mice. All mice immunized with SL3261(pTECH1) and SL3261-(pTECH1-P28) invoked a strong antibody response to TetC (Fig. 4) . Only mice immunized with SL3261(pTECHl-P28) elicited antibodies to P28 and at week 4 all 16 mice were positive after a single immunization (Fig. 4) not shown) demonstrated antibody to TetC and P28 detectable by week 3.
Groups of 10 mice were immunized orally with SL3261, SL3261(pTECH1), and SL3261(pTECH1-P28) and were bled from weeks 3, 7, and 10. Mice immunized with the constructs expressing TetC made antibody responses to TetC (Fig. 5) . Fromthe mice immunized with SL3261(pTECHl-P28) approximately half of the mice elicited antibodies to P28. No anti-TetC or anti-P28 antibodies were detected in mice immunized with SL3261 alone.
Tetanus Toxin and Salmonella Challenge. It is possible that the addition of a hinge domain and a guest antigen to the C terminus of TetC would destroy or mask epitopes important in eliciting protective immune responses to tetanus toxin. To investigate this possibility mice immunized with SL3261-(pTECH1) and SL3261(pTECHl-P28) were challenged with 50 times the lethal dose of tetanus toxin. The experiment was performed twice; from the mice that were immunized with SL3261(pTECH1) 8/10 and 11/14 mice were protected. However, all of the mice, 10/10 and 14/14, that were immunized with SL3261(pTECH1-P28) were solidly protected against the lethal effects of tetanus toxin challenge (Table 1) .
It cannot be excluded that the introduction of the constructs into the Salmonella strain SL3261 has had an adverse effect on the ability of the strain to protect against a virulent strain of S. typhimurium. Mice that had been immunized with SL3261(pTECHl-P28) and had also been challenged with tetanus toxin in the experiment described above ( Table 1 , experiment 1) were now challenged with 1000x LD5I virulent Salmonella strain C5, as were control groups of naive mice. In marked contrast to the naive mice, all of those that had been immunized with SL3261(pTECHl-P28) were completely protected (Table 2) .
DISCUSSION
The present results indicate that expression of recombinant antigens in salmonellae as C-terminal fusions to TetC driven by the nirB promoter merits consideration as an effective strategy for constructing combined Salmonella vaccines. We describe the construction of genetic fusions between the nontoxic but highly immunogenic TetC and a guest protein, the full-length S. mansoni P28 antigen. Responses were observed to the full-length P28 and also to TetC. The method has allowed us to obtain the response to an immunogenic antigen from S. mansoni in a Salmonella carrier.
Tetanus toxoid has been extensively used as an adjuvant to promote the immune response to chemically linked epitopes (12) . We have now shown that precise genetic fusions to TetC also result in immune responses to the guest antigens. Many heterologous genes expressed in bacteria are not produced in soluble, properly folded, or active forms and can accumulate as insoluble aggregates (31) . However, the TetC fusions to the full-length P28 protein are all soluble and are expressed in E. coli and S. typhimurium. In addition, the TetC-P28 protein fusion was capable of being affinity purified by a glutathione-agarose matrix, suggesting that the P28 had folded correctly to adopt a conformation still capable of binding to its natural substrate.
The salmonellae expressing the recombinant antigens all persisted in the mouse tissues as well as the parental strain, and the plasmids were not lost in vivo. We have observed that P28 expressed from the constitutive lac promoter in pUC19 was stable in vitro, but the Salmonella carrier quickly lost the plasmid when the strain was injected into mice; no antibody to P28 was detected (unpublished observations). The nature of the selective pressures operating in vivo to produce these differences is unclear. Furthermore, when we attempted to express the full-length P28 protein alone from nirB, the level of expression was much lower than that of the TetC-P28 fusions described above and the construct was not immunogenic (unpublished observations).
It may be that the immune response has been promoted by the carrier TetC providing additional T-cell helper epitopes It is conceivable that the addition of a hinge domain and a guest antigen to the C terminus of TetC has perhaps destroyed or masked epitopes important in eliciting protective immune responses to tetanus toxoid. To investigate this possibility, mice immunized with the recombinant salmonellae were challenged with 50 times the lethal dose of tetanus toxin. Not all of the mice that were immunized with SL3261(pTECH1) were protected; however, mice immunized with SL3261(pTECH1-P28) were solidly protected against the lethal effects of tetanus toxin challenge. In the case of pTECH1 it is possible that the introduction of a hinge domain and cloning region alone affects the folding of the TetC protein, perhaps destroying potentially protective epitopes. However, upon fusion to P28 this effect may be counteracted to restore the protection levels to 100%. Furthermore, the same mice were totally protected against challenge by a lethal dose of virulent Salmonella, suggesting that the constructs had not affected the ability of the host strain to elicit protective immunity.
One of the advantages of using salmonellae as delivery systems is precisely their ability to stimulate cell-mediated immunity, and the induction of T-cell responses to P28 requires further investigation. T-cell responses to recombinant influenza nucleoprotein (33) and cytotoxic T-cell responses to Plasmodium circumsporozoite antigens (7) have been described with the Salmonella delivery system. The ability of salmonellae to colonize precisely in the reticuloendothelial system may be a factor in their capacity to trigger humoral and cellular responses, which could be an advantage for eliciting protection against disease. We have investigated the ability of SL3261(pTECH1-P28) to protect mice against a challenge infection with S. mansoni, and preliminary results show that a significant reduction in worm burden is achieved after a single oral inoculation compared to control mice inoculated with the construct expressing TetC alone (unpublished data). Of great importance, the TetC-P28 fusion protein is stably expressed in the human live typhoid vaccine strain S. typhi Ty21A (unpublished observations). Live attenuated Aro-human typhoid vaccines are presently undergoing promising trials in human volunteers (34) . It may be that a live trivalent typhoid-tetanus-schistosome vaccine could be feasible.
